← All stocks

IDEAYA Biosciences, Inc.

IDYA Net buying
CIK 0001676725 #1584 in the set updated 17 Sep 2026
Bought (120 mo)
$24.37M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$34.91M
$719.03K on a plan · $22.05M straight out of an exercise
Sold at will
$12.14M
14 of 84 sales
Net
−$10.54M
+$12.23M against sales at will

By person

16 insiders · 119 transactions
39.4×

Yujiro S. Hata holds 39.4 times base salary in stock. $27.64M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Yujiro S. Hata last reported holding, valued at $40.01, the price Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hata Yujiro S
President and CEO
$17.56M (14) scheduled
−$17.56M
690,695
0.7158%
$27.64M
+15.9%
CANAAN X L.P.
10% owner
$4.00M (1)
+$4.00M
2,660,713
2.76%
$106.46M
SHANNON TIMOTHY M
Director
$4.00M (1)
+$4.00M
2,660,713
2.76%
$106.46M
5AM Ventures IV, L.P. entity
10% owner
$7.50M (3)
$10.93M (3)
−$3.43M
384,496
0.3985%
$15.39M
DIEKMAN JOHN D
Director
$2.50M (2)
+$2.50M
118,521
0.1228%
$4.74M
Stone Paul A.
Chief Financial Officer
$2.50M (2)
$463.15K (9) scheduled
+$2.04M
127,824
0.1325%
$5.11M
Stein Jeffrey
Director
$1.65M (1)
+$1.65M
54,281
0.0563%
$2.17M
+1,168%
Throne Jason
Chief Legal Officer
$1.62M (19) scheduled
−$1.62M
63,484
0.0658%
$2.54M
+1,417%
Dillon Michael P.
SVP, Chief Scientific Officer
$1.50M (16) scheduled
−$1.50M
78,789
0.0817%
$3.15M
−13.5%
WHITE MICHAEL ANTHONY
Chief Scientific Officer
$1.03M (2) scheduled
−$1.03M
0
0.0000%
$0.00
BVF PARTNERS L P/IL entity
See Explanation of Responses
$1.72M (9)
$835.36K (3)
+$887.27K
233,150
0.2416%
$9.33M
+46.6%
Ruiz Briseno Andres
Chief Accounting Officer
$762.27K (7) scheduled
−$762.27K
26,466
0.0274%
$1.06M
−23.4%
Alexandria Venture Investments, LLC entity
10% owner
$500.00K (1)
+$500.00K
432,384
0.4481%
$17.30M
Lackner Mark
SVP, Head of Biology
$204.18K (11) scheduled
−$204.18K
0
0.0000%
$0.00
−100.0%
Hager Jeffrey
SVP, Chief Technology Officer
127,853
0.1325%
$5.12M
+19.6%
Snyder Douglas B.
SVP, General Counsel
2,080
0.0022%
$83.23K
Insider
Date
Role
Action
Shares
Price
Amount
Ruiz Briseno Andres
7 Jul 2026
Chief Accounting Officer
Sold after exercise
9,550
$40.01
$382.13K
WHITE MICHAEL ANTHONY
29 May 2024
Chief Scientific Officer
Sold after exercise
851
$36.78
$31.30K
WHITE MICHAEL ANTHONY
29 May 2024
Chief Scientific Officer
Sold after exercise
27,649
$36.23
$1.00M
Hata Yujiro S
16 May 2024
President and CEO
Sold after exercise
4,349
$42.37
$184.25K
Hata Yujiro S
16 May 2024
President and CEO
Sold after exercise
30,084
$41.73
$1.26M
Hata Yujiro S
15 May 2024
President and CEO
Sold after exercise
503
$44.12
$22.19K
Hata Yujiro S
15 May 2024
President and CEO
Sold after exercise
29,761
$43.48
$1.29M
Hata Yujiro S
15 May 2024
President and CEO
Sold after exercise
53,592
$42.57
$2.28M
Hata Yujiro S
14 May 2024
President and CEO
Sold after exercise
2,303
$41.84
$96.35K
Hata Yujiro S
14 May 2024
President and CEO
Sold after exercise
54,408
$41.60
$2.26M
Hata Yujiro S
9 Feb 2024
President and CEO
Sold after exercise
23,557
$45.54
$1.07M
Hata Yujiro S
8 Feb 2024
President and CEO
Sold after exercise
75,815
$45.15
$3.42M
Hata Yujiro S
1 Feb 2024
President and CEO
Sold after exercise
4
$45.01
$180.04
Hata Yujiro S
1 Feb 2024
President and CEO
Sold after exercise
624
$45.00
$28.08K
Hata Yujiro S
16 Jan 2024
President and CEO
Sold after exercise
62,739
$40.17
$2.52M
Hata Yujiro S
12 Jan 2024
President and CEO
Sold after exercise
12,261
$40.04
$490.91K
Hata Yujiro S
15 Dec 2023
President and CEO
Sold after exercise
75,000
$35.03
$2.63M
Throne Jason
15 Dec 2023
Chief Legal Officer
Sold after exercise
10,000
$35.04
$350.37K
Throne Jason
3 Nov 2023
Chief Legal Officer
Sold after exercise
5,163
$30.09
$155.36K
Throne Jason
12 Sep 2023
Chief Legal Officer
Sold after exercise
500
$30.01
$15.01K
Throne Jason
12 Sep 2023
Chief Legal Officer
Sold after exercise
500
$30.00
$15.00K
Throne Jason
5 Sep 2023
Chief Legal Officer
Sold after exercise
1,737
$30.03
$52.16K
Throne Jason
1 Sep 2023
Chief Legal Officer
Sold after exercise
2,100
$30.03
$63.06K
Throne Jason
9 Aug 2023
Chief Legal Officer
Sold after exercise
5,000
$25.09
$125.43K
Throne Jason
10 Jul 2023
Chief Legal Officer
Sold after exercise
9,485
$23.00
$218.18K
Throne Jason
1 Jun 2023
Chief Legal Officer
Sold after exercise
3,553
$23.02
$81.79K
Throne Jason
31 May 2023
Chief Legal Officer
Sold after exercise
432
$23.00
$9.94K
Throne Jason
22 May 2023
Chief Legal Officer
Sold after exercise
500
$23.00
$11.50K
Dillon Michael P.
4 Oct 2021
SVP, Chief Scientific Officer
Sold after exercise
1,000
$26.62
$26.62K
Dillon Michael P.
4 Oct 2021
SVP, Chief Scientific Officer
Sold after exercise
500
$25.85
$12.92K
Dillon Michael P.
8 Sep 2021
SVP, Chief Scientific Officer
Sold after exercise
200
$27.67
$5.53K
Dillon Michael P.
8 Sep 2021
SVP, Chief Scientific Officer
Sold after exercise
11,184
$27.41
$306.56K
Dillon Michael P.
7 Sep 2021
SVP, Chief Scientific Officer
Sold after exercise
116
$27.46
$3.19K
Dillon Michael P.
9 Aug 2021
SVP, Chief Scientific Officer
Sold after exercise
400
$23.52
$9.41K
Dillon Michael P.
9 Aug 2021
SVP, Chief Scientific Officer
Sold after exercise
11,100
$22.96
$254.86K
Throne Jason
27 Jul 2021
SVP, General Counsel
Sold after exercise
10,000
$25.17
$251.68K
Dillon Michael P.
27 Jul 2021
SVP, Chief Scientific Officer
Sold after exercise
10,000
$25.15
$251.46K
Throne Jason
6 Jul 2021
SVP, General Counsel
Sold after exercise
359
$22.68
$8.14K
Throne Jason
6 Jul 2021
SVP, General Counsel
Sold after exercise
2,031
$22.16
$45.02K
Throne Jason
6 Jul 2021
SVP, General Counsel
Sold after exercise
1,142
$22.68
$25.90K
Throne Jason
6 Jul 2021
SVP, General Counsel
Sold after exercise
6,468
$22.16
$143.36K
Dillon Michael P.
6 Jul 2021
SVP, Chief Scientific Officer
Sold after exercise
100
$22.76
$2.28K
Dillon Michael P.
6 Jul 2021
SVP, Chief Scientific Officer
Sold after exercise
1,400
$22.20
$31.08K
Dillon Michael P.
17 Jun 2021
SVP, Chief Scientific Officer
Sold after exercise
3,893
$22.49
$87.54K
Dillon Michael P.
16 Jun 2021
SVP, Chief Scientific Officer
Sold after exercise
1,107
$22.47
$24.87K
Dillon Michael P.
7 Jun 2021
SVP, Chief Scientific Officer
Sold after exercise
1,500
$20.22
$30.33K
Dillon Michael P.
11 May 2021
SVP, Chief Scientific Officer
Sold after exercise
5,000
$20.22
$101.09K
Lackner Mark
10 Feb 2021
SVP, Head of Biology
Sold after exercise
596
$21.00
$12.52K
Lackner Mark
9 Feb 2021
SVP, Head of Biology
Sold after exercise
1,104
$21.05
$23.23K
Dillon Michael P.
9 Feb 2021
SVP, Chief Scientific Officer
Sold after exercise
5,000
$20.74
$103.70K
Lackner Mark
8 Feb 2021
SVP, Head of Biology
Sold after exercise
200
$21.00
$4.20K
Lackner Mark
8 Feb 2021
SVP, Head of Biology
Sold after exercise
100
$21.02
$2.10K
Lackner Mark
26 Jan 2021
SVP, Head of Biology
Sold after exercise
800
$18.79
$15.03K
Lackner Mark
26 Jan 2021
SVP, Head of Biology
Sold after exercise
1,701
$18.30
$31.12K
Lackner Mark
17 Jun 2020
SVP, Head of Biology
Sold after exercise
373
$19.91
$7.43K
Stone Paul A.
17 Jun 2020
Chief Financial Officer
Sold after exercise
600
$19.95
$11.97K
Stone Paul A.
17 Jun 2020
Chief Financial Officer
Sold after exercise
2,500
$17.50
$43.75K
Lackner Mark
16 Jun 2020
SVP, Head of Biology
Sold after exercise
6,750
$14.93
$100.76K

What was left out

Form 4 filings counted 166
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 58
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 12,886,121
Sales filed before the plan box existed 14
History held since 28 May 2019